Literature DB >> 17001602

Hypophosphorylation of the architectural chromatin protein DEK in death-receptor-induced apoptosis revealed by the isotope coded protein label proteomic platform.

Anja Tabbert1, Ferdinand Kappes, Rolf Knippers, Josef Kellermann, Friedrich Lottspeich, Elisa Ferrando-May.   

Abstract

During apoptosis nuclear morphology changes dramatically due to alterations of chromatin architecture and cleavage of structural nuclear proteins. To characterize early events in apoptotic nuclear dismantling we have performed a proteomic study of apoptotic nuclei. To this end we have combined a cell-free apoptosis system with a proteomic platform based on the differential isotopic labeling of primary amines with N-nicotinoyloxy-succinimide. We exploited the ability of this system to produce nuclei arrested at different stages of apoptosis to analyze proteome alterations which occur prior to or at a low level of caspase activation. We show that the majority of proteins affected at the onset of apoptosis are involved in chromatin architecture and RNA metabolism. Among them is DEK, an architectural chromatin protein which is linked to autoimmune disorders. The proteomic analysis points to the occurrence of multiple PTMs in early apoptotic nuclei. This is confirmed by showing that the level of phosphorylation of DEK is decreased following apoptosis induction. These results suggest the unexpected existence of an early crosstalk between cytoplasm and nucleus during apoptosis. They further establish a previously unrecognized link between DEK and cell death, which will prove useful in the elucidation of the physiological function of this protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001602     DOI: 10.1002/pmic.200600197

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

2.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

3.  A DEK domain-containing protein modulates chromatin structure and function in Arabidopsis.

Authors:  Sascha Waidmann; Branislav Kusenda; Juliane Mayerhofer; Karl Mechtler; Claudia Jonak
Journal:  Plant Cell       Date:  2014-11-11       Impact factor: 11.277

4.  High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.

Authors:  Jörg Fahrer; Oliver Popp; Maria Malanga; Sascha Beneke; David M Markovitz; Elisa Ferrando-May; Alexander Bürkle; Ferdinand Kappes
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

Review 5.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.

Authors:  Yan Liu; Oriana E Hawkins; Anna E Vilgelm; Jeffrey S Pawlikowski; Jeffrey A Ecsedy; Jeffrey A Sosman; Mark C Kelley; Ann Richmond
Journal:  Clin Cancer Res       Date:  2015-07-07       Impact factor: 12.531

7.  DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.

Authors:  F Kappes; J Fahrer; M S Khodadoust; A Tabbert; C Strasser; N Mor-Vaknin; M Moreno-Villanueva; A Bürkle; D M Markovitz; E Ferrando-May
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

8.  The human DEK oncogene regulates DNA damage response signaling and repair.

Authors:  Gina M Kavanaugh; Trisha M Wise-Draper; Richard J Morreale; Monique A Morrison; Boris Gole; Sandy Schwemberger; Elisia D Tichy; Lu Lu; George F Babcock; James M Wells; Rachid Drissi; John J Bissler; Peter J Stambrook; Paul R Andreassen; Lisa Wiesmüller; Susanne I Wells
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

9.  Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.

Authors:  Takayuki Nakashima; Hiroyuki Tomita; Akihiro Hirata; Kazuhisa Ishida; Kenji Hisamatsu; Yuichiro Hatano; Tomohiro Kanayama; Ayumi Niwa; Kei Noguchi; Keizo Kato; Tatsuhiko Miyazaki; Takuji Tanaka; Toshiyuki Shibata; Akira Hara
Journal:  Cancer Med       Date:  2017-08-23       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.